Literature DB >> 16793503

Meningioma.

Brian Goldsmith1, Michael W McDermott.   

Abstract

Total excision is an appropriate treatment option for patients with benign meningiomas that are resectable with minimal morbidity. It is particularly appropriate for patients with significant mass effect causing symptoms. Fractionated conformal radiotherapy is an appropriate primary treatment option for patients with benign meningiomas of all sizes and all sites. It is particularly appropriate and preferred for optic nerve sheath meningiomas, for which there are few alternatives. Planned subtotal resection is appropriate if decompression is expected to relieve acute symptoms. After subtotal resection, it is appropriate to offer single-fraction radiosurgery or multifraction radiotherapy, depending on the size, location, and extent of residual tumor, so as to achieve progression-free survival and cause-specific survival rates comparable to those of other approaches.

Entities:  

Mesh:

Year:  2006        PMID: 16793503     DOI: 10.1016/j.nec.2006.03.002

Source DB:  PubMed          Journal:  Neurosurg Clin N Am        ISSN: 1042-3680            Impact factor:   2.509


  11 in total

1.  Is there effective systemic therapy for recurrent surgery- and radiation-refractory meningioma?

Authors:  Marc C Chamberlain
Journal:  CNS Oncol       Date:  2013-01

2.  Hydroxyurea for recurrent surgery and radiation refractory high-grade meningioma.

Authors:  Marc C Chamberlain
Journal:  J Neurooncol       Date:  2011-11-30       Impact factor: 4.130

3.  Management of petroclival meningiomas: a review of the development of current therapy.

Authors:  Adrian J Maurer; Sam Safavi-Abbasi; Ahmed A Cheema; Chad A Glenn; Michael E Sughrue
Journal:  J Neurol Surg B Skull Base       Date:  2014-05-27

4.  Hydroxyurea for recurrent surgery and radiation refractory meningioma: a retrospective case series.

Authors:  Marc C Chamberlain; Sandra K Johnston
Journal:  J Neurooncol       Date:  2011-02-13       Impact factor: 4.130

Review 5.  Medical therapies for meningiomas.

Authors:  Patrick Y Wen; Eudocia Quant; Jan Drappatz; Rameen Beroukhim; Andrew D Norden
Journal:  J Neurooncol       Date:  2010-09-04       Impact factor: 4.130

6.  IFN-α for recurrent surgery- and radiation-refractory high-grade meningioma: a retrospective case series.

Authors:  Marc C Chamberlain
Journal:  CNS Oncol       Date:  2013-05

7.  uPA/uPAR downregulation inhibits radiation-induced migration, invasion and angiogenesis in IOMM-Lee meningioma cells and decreases tumor growth in vivo.

Authors:  Odysseas Kargiotis; Chandramu Chetty; Venkateswara Gogineni; Christopher S Gondi; Sai Muralikrishna Pulukuri; Athanassios P Kyritsis; Meena Gujrati; Jeffrey D Klopfenstein; Dzung H Dinh; Jasti S Rao
Journal:  Int J Oncol       Date:  2008-11       Impact factor: 5.650

8.  Foramen magnum meningioma: Dysphagia of atypical etiology.

Authors:  Gabriel J Tsao; Matthew W Tsang; Bret C Mobley; Walter W Cheng
Journal:  J Gen Intern Med       Date:  2007-12-15       Impact factor: 5.128

Review 9.  Calcification of vestibular schwannoma: a case report and literature review.

Authors:  Yang Zhang; Jinlu Yu; Limei Qu; Yunqian Li
Journal:  World J Surg Oncol       Date:  2012-10-02       Impact factor: 2.754

10.  Impact of anterior clinoidectomy on visual function after resection of meningiomas in and around the optic canal.

Authors:  Jens Lehmberg; Sandro M Krieg; Barbara Mueller; Bernhard Meyer
Journal:  Acta Neurochir (Wien)       Date:  2013-05-11       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.